Canada markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
39.80+1.38 (+3.59%)
At close: 04:00PM EDT
40.68 +0.88 (+2.21%)
After hours: 07:19PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
6,072
6,883
2,357
4,651
7,418
Operating Expenses
Research Development
122,874
118,011
82,258
53,311
42,534
Selling General and Administrative
33,377
30,914
27,195
20,488
14,456
Total Operating Expenses
156,251
148,925
109,453
73,799
56,990
Operating Income or Loss
-150,179
-142,042
-107,096
-69,148
-49,572
Total Other Income/Expenses Net
5,303
613
-5,229
-1,590
-11,375
Income Before Tax
-144,876
-141,429
-112,325
-70,738
-60,947
Income Tax Expense
-
0
0
-227
-1,167
Income from Continuing Operations
-144,876
-141,429
-112,325
-70,511
-59,780
Net Income
-144,876
-141,429
-112,325
-70,511
-59,780
Net Income available to common shareholders
-144,876
-141,429
-112,325
-70,511
-59,780
Basic EPS
-1.64
-2.92
-2.40
-1.64
-2.02
Diluted EPS
-1.64
-2.92
-2.40
-1.64
-2.02
Basic Average Shares
42,870
48,449
46,888
42,870
29,640
Diluted Average Shares
42,870
48,449
46,888
42,870
29,640